Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phathom Pharmaceuticals, Inc. (PHAT)
:PHAT
RESEARCH TOOLSreports
Holding PHAT?
Track your performance easily
Phathom Pharmaceuticals (PHAT) Ownership Overview
18.29% Insiders
15.59% Mutual Funds
0.11% Other Institutional Investors
8.53% ETFs
57.48% Public Companies and Individual Investors
The ownership structure of Phathom Pharmaceuticals (PHAT) stock is a mix of institutional, retail, and individual investors. Approximately 24.23% of the company’s stock is owned by Institutional Investors, 18.29% is owned by Insiders, and 57.48% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 20, 2024 | Molly Henderson Cfo And Cbo | xxxxxxxxxxxxx | $10328 |
| Dec 20, 2024 | Azmi Nabulsi Coo | xxxxxxxxxxxxx | $8944 |
| Dec 16, 2024 | Asit Parikh Director | xxxxxxxxxxxxx | $81200 |
| Dec 16, 2024 | Frank Karbe Director | xxxxxxxxxxxxx | $99000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $2350400 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $13550724 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $29341724 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $46527288 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,863,424 | Insider | 8.58% | 41,806,213 | |
| 3,755,583 | Insider | 5.49% | 26,777,307 | |
| 2,573,412 | Institution | 3.76% | 18,348,428 | |
| 2,463,519 | Institution | 3.60% | 17,564,890 | |
| 2,202,267 | Institution | 3.22% | 15,702,164 | |
| 2,069,382 | Institution | 3.03% | 14,754,694 | |
| 1,972,750 | Institution | 2.89% | 14,065,708 | |
| 1,674,185 | Institution | 2.45% | 11,936,939 | |
| 1,622,883 | Institution | 2.37% | 11,571,156 | |
| 1,231,255 | Insider | 1.80% | 8,778,848 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,202,267 | Institution | 3.22% | 15,702,164 | |
| 1,972,750 | Institution | 2.89% | 14,065,708 | |
| 1,674,185 | Institution | 2.45% | 11,936,939 | |
| 862,554 | Institution | 1.26% | 6,150,010 | |
| 746,710 | Institution | 1.09% | 5,324,042 | |
| 464,839 | Institution | 0.68% | 3,314,302 | |
| 385,704 | Institution | 0.56% | 2,750,070 | |
| 382,518 | Institution | 0.56% | 2,727,353 | |
| 253,000 | Institution | 0.37% | 1,803,890 | |
| 227,003 | Institution | 0.33% | 1,618,531 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,588,583 | Institution | 2.32% | 14,090,731 | |
| 1,027,304 | Institution | 1.50% | 7,324,678 | |
| 581,935 | Institution | 0.85% | 3,951,339 | |
| 557,349 | Institution | 0.82% | 4,943,686 | |
| 283,993 | Institution | 0.42% | 2,024,870 | |
| 225,931 | Institution | 0.33% | 1,610,888 | |
| 215,877 | Institution | 0.32% | 1,465,805 | |
| 183,097 | Institution | 0.27% | 1,243,229 | |
| 160,199 | Institution | 0.23% | 1,420,965 | |
| 124,321 | Institution | 0.18% | 1,102,727 |
FAQ
Who Owns Phathom Pharmaceuticals, Inc. (PHAT)?
According to the latest TipRanks data, approximately 0.11% of the company's stock is held by institutional investors, 18.29% is held by insiders, and 57.48% is held by retail investors.
What percentage of Phathom Pharmaceuticals, Inc. (PHAT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.11% of Phathom Pharmaceuticals, Inc. (PHAT) stock is held by institutional investors.
What percentage of Phathom Pharmaceuticals, Inc. (PHAT) stock is held by retail investors?
According to the latest TipRanks data, approximately 57.48% of Phathom Pharmaceuticals, Inc. (PHAT) stock is held by retail investors.
Who owns the most shares of Phathom Pharmaceuticals, Inc. (PHAT)?
James Topper owns the most shares of Phathom Pharmaceuticals, Inc. (PHAT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.